A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)

计划入组 452 人 · 首次发布于 2013 年 4 月 12 日

Efficacy and Safety of THR-4109 in Obese Subjects

计划入组 220 人 · 首次发布于 2007 年 6 月 12 日

Study to Assess the Safety and Efficacy of THR-18 When Administered to Patients Suffering Acute Ischemic Stroke and Treated With Tissue Plasminogen Activator (tPA)

计划入组 22 人 · 首次发布于 2010 年 12 月 3 日

THR-18

THR-687

THR-8590

Australian Supplements

Australia

GlyTech, Inc.

Japan

KEY THERAPEUTICS, LLC

United States

DRI Scientists Achieve Diabetes Reversal Using Small Peptide THR-123 in Preclinical Models

TILT Biotherapeutics Presents Promising Clinical Data on Intravenous TILT-123 at ESMO 2024

Asahi Kasei Pharma Initiates Phase III Trial of ART-123 for Chemotherapy-Induced Peripheral Neuropathy Prevention